Paul C. Langley - Publications, H-index & Citations

Paul C. Langley

University of Minnesota Twin Cities

30H指数

189论文数

3.1K被引数

收录论文 20

发表时间

Fundamental Measurement and Quality-Adjusted Life Years

VALUE IN HEALTH

IF6

2021-03-01

OAAI

Langley, Paul C.; McKenna, Stephen P.

IMAGINARY WORLDS: THE STATUS OF MODELED CLAIMS PUBLISHED IN VALUE IN HEALTH JANUARY 2015 TO DECEMBER 2015

VALUE IN HEALTH

IF6

2016-05-01

OAAI

Langley, P. C.; Schommer, J.; Rhee, T. G.

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2012-06-01

PREAI

Langley, P.; Nuki, G.; Forsythe, A.

The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan

VALUE IN HEALTH

IF6

2012-01-01

OAAI

Liu, Gordon G.; DiBonaventura, Marco daCosta; Yuan, Yong; Wagner, Jan-Samuel; L'Italien, Gilbert J.; Langley, Paul; Kamae, Isao

THE BURDEN OF VIRAL HEPATITIS C IN EUROPE: A PROPENSITY ANALYSIS OF PATIENT OUTCOMES

JOURNAL OF HEPATOLOGY

IF33

2011-03-01

OAAI

Di Bonaventura, M.; Yuan, Y.; Wagner, J. -S.; L'Italien, G.; McEwan, P.; Langley, P.

Concurrent asthma controller medication possession profiles in an adult managed care population

VALUE IN HEALTH

IF6

2008-05-01

OAAI

Wagner, S.; Langley, P.

Bi-modality in distribution of medication possession ratios for asthma controller therapies

VALUE IN HEALTH

IF6

2007-11-01

OAAI

Langley, P.; Wagner, S.

Cost-effectiveness of extended-release and immediate-release tramadol for the treatment of chronic osteoarthritis pain

VALUE IN HEALTH

IF6

2007-05-01

OAAI

Patkar, A. D.; Langley, P.; Janagap, C.; Meyer, K.; Grogg, A.; Turk, D. C.

A retrospective evaluation of HBAIC goal attainment among various diabetes treatment regimens in a managed care population

VALUE IN HEALTH

IF6

2007-05-01

OAAI

Abarca, J.; White, T. J.; Langley, P.; Yokoyama, K.; Campbell, H. E.

A retrospective analysis of costs and patterns of treatment for external genital warts in the Netherlands

CLINICAL THERAPEUTICS

IF3.6

2002-01-01

PREAI

van der Meijden, WI; Notowicz, A; Blog, FB; Langley, PC

Modeling the impact of treatment options in genital warts: Patient-applied versus physician-administered therapies

CLINICAL THERAPEUTICS

IF3.6

1999-12-01

PREAI

Langley, PC; Richwald, GA; Smith, MH

Meeting the information needs of drug purchasers: The evolution of formulary submission guidelines

CLINICAL THERAPEUTICS

IF3.6

1999-04-01

PREAI

Langley, PC

The technology of metered-dose inhalers and treatment costs in asthma: A retrospective study of breath actuation versus traditional press-and-breathe inhalers

CLINICAL THERAPEUTICS

IF3.6

1999-01-01

PREAI

Langley, PC

A review of cost-of-illness studies on obesity

CLINICAL THERAPEUTICS

IF3.6

1998-07-01

PREAI

Kortt, MA; Langley, PC; Cox, ER

A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgery 依诺肝素和华法林预防膝关节置换手术患者深静脉血栓形成的药物经济学评估

CLINICAL THERAPEUTICS

IF3.6

1998-01-01

PREAI

Hawkins, DW; Langley, PC; Krueger, KP

Risperidone versus haloperidol: II. Cost-effectiveness

CLINICAL THERAPEUTICS

IF3.6

1998-01-01

PREAI

Davies, A; Langley, PC; Keks, NA; Catts, SV; Lambert, T; Schweitzer, I

Improving health care outcomes through reallocation of health care expenditures

CLINICAL THERAPEUTICS

IF3.6

1997-09-01

PREAI

Langley, PC

Treatment costs, equilibrium, and the allocation of patients to therapy alternatives

CLINICAL THERAPEUTICS

IF3.6

1997-07-01

PREAI

Langley, PC; Bhattacharyya, SK

The future of pharmacoeconomics: A commentary

CLINICAL THERAPEUTICS

IF3.6

1997-07-01

PREAI

Langley, PC

Assessing the input costs of disease management programs

CLINICAL THERAPEUTICS

IF3.6

1996-11-01

PREAI

Langley, PC

研究方向